Allen Annis

Allen Annis has served as our Senior Vice President, Research, since November 2018. Dr. Annis joined our company in November 2007 and served as our Senior Director, Biophysical and Analytical Technology, from November 2007 to September 2009, and as our Vice President of Research from September 2009 to November 2018. Previously, Dr. Annis served as Director of Technology Development at Schering-Plough Research Institute, and as Vice President of New Technologies at NeoGenesis Pharmaceuticals, Inc. While at NeoGenesis, Dr. Annis co-developed the company’s core drug discovery platform, the affinity selection-mass spectrometry-based Automated Ligand Identification System, or ALIS. Dr. Annis authored the key patents and publications that describe the ALIS technology and invented novel ALIS-based techniques to study protein-drug interactions. Dr. Annis received a M.A. and Ph.D. in chemistry from Harvard University, and a B.S. in chemistry from Georgia Institute of Technology.